ZyVersa Therapeutics Forms New Scientific Advisory Board to Support Development of Inflammasome ASC Inhibitor IC 100 for Obesity with Metabolic Complications - ZyVersa Therapeutics ( NASDAQ:ZVSA )

2 weeks ago

New Scientific Advisory Board ( SAB ) comprised of five leading experts in the areas of obesity and metabolic diseases, and four leading inflammasome experts and inventors of IC 100 from University of Miami Miller School of Medicine who have provided ongoing scientific advisory support for IC ...

Ticker	Sentiment	Impact
ZVSA	Neutral	12 %